# Local Consolidative Radiation Therapy Plus TKI Versus TKI Alone in Driver Mutated OM-NSCLC

> **NCT05277844** · PHASE2 · RECRUITING · sponsor: **Tata Memorial Hospital** · enrollment: 106 (estimated)

## Conditions studied

- Oligometastatic Disease
- Non-small Cell Lung Cancer
- Driver Mutation

## Interventions

- **RADIATION:** Local Consolidative Radiation Therapy
- **DRUG:** TKI

## Key facts

- **NCT ID:** NCT05277844
- **Lead sponsor:** Tata Memorial Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-11-11
- **Primary completion:** 2026-11-11
- **Final completion:** 2027-11-11
- **Target enrollment:** 106 (ESTIMATED)
- **Last updated:** 2025-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05277844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05277844, "Local Consolidative Radiation Therapy Plus TKI Versus TKI Alone in Driver Mutated OM-NSCLC". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05277844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*